Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open - United Kingdom
doi 10.1136/rmdopen-2017-000445